Vanda Pharmaceuticals Inc.
—- Market cap
- $317.43M
- Debt
- —
- Cash
- −$84.85M
Complete market value, debt and cash evidence is required for enterprise value.
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
VNDA · price snapshotP/S 1.47x
$5.25Snapshot Sep 9, 2026, 4:00 PM ET
Implied fair value · at VIAV's multiple
$22.76333.5% above market
3.57 VNDA revenue / share×6.37x VIAV P/S=$22.76
Market $5.25Implied $22.76
VIAV · price snapshotP/S 6.37x
$39.18Snapshot Sep 9, 2026, 4:00 PM ET
Implied fair value · at VNDA's multiple
$9.0476.9% below market
6.15 VIAV revenue / share×1.47x VNDA P/S=$9.04
Market $39.18Implied $9.04